Want to see CRBU full AI Analyst Report?
Caribou Biosciences (CRBU) Income Statement
Caribou Biosciences Income Statement
Last quarter (Q2 2026), Caribou Biosciences's total revenue was $1.50M, a decrease of 43.79% from the same quarter last year. In Q2, Caribou Biosciences's net income was $-24.28M. See Caribou Biosciences’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 11.16M | $ 9.99M | $ 34.48M | $ 13.85M | $ 9.60M | |
| $ 7.51M | $ 6.07M | $ 30.95M | $ 10.21M | $ 8.61M | |
| $ 143.71M | $ 172.68M | $ 147.01M | $ 116.61M | $ 75.59M | |
| Depreciation and Amortization | $ 3.65M | $ 3.93M | $ 3.52M | $ 1.62M | $ 984.00K |
| $ -145.03M | $ -145.19M | $ -98.35M | $ -97.73M | $ -65.61M | |
| $ -136.19M | $ -166.62M | $ -116.06M | $ -106.40M | $ -66.98M | |
| $ -12.48M | $ 17.50M | $ 14.18M | $ 7.05M | $ 377.00K | |
| $ -148.68M | $ -149.11M | $ -101.88M | $ -99.35M | $ -66.60M | |
| $ -148.13M | $ -149.10M | $ -102.07M | $ -99.42M | $ -66.92M | |
| Per Share Metrics | |||||
| Basic EPS | $ -1.59 | $ -1.65 | $ -1.38 | $ -1.64 | $ -1.11 |
| Diluted EPS | $ -1.59 | $ -1.65 | $ -1.38 | $ -1.64 | $ -1.11 |
| Weighted Average Shares Outstanding | 93.39M | 90.32M | 73.81M | 60.80M | 60.26M |
| Weighted Average Shares Outstanding (Diluted) | 93.39M | 90.32M | 73.81M | 60.80M | 60.26M |
Currency in USD